pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
lenvatinib mesylate
Lenvima (lenvatinib mesylate)
Renal Cell Carcinoma
Vascular endothelial growth factor receptor
Eisai Co Ltd
2 catalysts
Phase 2
teverelix
teverelix [INN]
Prostate Cancer
Antev Ltd
2 catalysts
Marketed
eflornithine hydrochloride
Iwilfin (eflornithine hydrochloride)
Neuroblastoma
US WorldMeds LLC
1 catalysts
← prev
page 3 of 62
next →
131
Pain89
Neurology1
Marketed
inavolisib
Itovebi (inavolisib)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
F. Hoffmann-La Roche Ltd
3 catalysts
Marketed
imetelstat sodium
Rytelo (imetelstat sodium)
Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Telomerase reverse transcriptase
$GERNGERON CORP
2 catalysts
Marketed
quizartinib dihydrochloride
Vanflyta (quizartinib dihydrochloride)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Daiichi Sankyo Co Ltd
3 catalysts
Marketed
METHYLPREDNISOLONE ACETATE
METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE)
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease)
Hong Kong King-Friend Pharmaceutical Co Ltd
41 catalysts
Marketed
lutetium Lu 177 vipivotide tetraxetan
Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
Hormone-Sensitive Prostate Cancer
Glutamate carboxypeptidase 2
$NVSNOVARTIS AG
4 catalysts
Marketed
(berahyaluronidase alfa + pembrolizumab)
Keytruda Qlex ((berahyaluronidase alfa-pmph + pembrolizumab))
Muscle Invasive Bladder Cancer (MIBC)
$MRKMerck & Co., Inc.
5 catalysts
Marketed
epcoritamab
Epkinly (epcoritamab-bsyp)
Diffuse Large B-Cell Lymphoma
Genmab AS
5 catalysts
Marketed
niraparib
Zejula (niraparib)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Poly [ADP-ribose] polymerase 2Poly [ADP-ribose] polymerase 1
$JNJJOHNSON & JOHNSON
5 catalysts
Marketed
Spexotras
Mekinist (trametinib dimethyl sulfoxide)
Low-Grade Glioma
$NVSNOVARTIS AG
43 catalysts
Marketed
dabrafenib mesylate ODT
Tafinlar (dabrafenib mesylate)
Low-Grade Glioma
$NVSNOVARTIS AG
40 catalysts
Marketed
trastuzumab emtansine
Kadcyla (trastuzumab emtansine)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Receptor tyrosine-protein kinase erbB-2Tubulin
Genentech Inc
14 catalysts
Marketed
CINACALCET HYDROCHLORIDE
CINACALCET HYDROCHLORIDE (CINACALCET HYDROCHLORIDE)
Hypercalcemia
Slate Run Pharmaceuticals LLC
6 catalysts
Marketed
fedratinib
Inrebic (fedratinib)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Bristol-Myers Squibb Co
7 catalysts
Marketed
pacritinib
Vonjo (pacritinib)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Sobi Inc
6 catalysts
Marketed
momelotinib dihydrochloride
Ojjaara (momelotinib dihydrochloride)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
GlaxoSmithKline LLC
4 catalysts
Marketed
polatuzumab vedotin
Polivy (polatuzumab vedotin-piiq)
Diffuse Large B-Cell Lymphoma
Genentech Inc
4 catalysts
Marketed
OXALIPLATIN
OXALIPLATIN (OXALIPLATIN)
Colon Cancer
Ingenus Pharmaceuticals LLC
4 catalysts
Marketed
GEMCITABINE HYDROCHLORIDE
GEMCITABINE HYDROCHLORIDE (GEMCITABINE HYDROCHLORIDE)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
DNA polymerase (alpha/delta/epsilon)Ribonucleoside-diphosphate reductase RR1
$JNJJOHNSON & JOHNSON
3 catalysts
Marketed
omeprazole DR
Prilosec (omeprazole)
Multiple Endocrine Adenomas
Covis Pharmaceuticals Inc (Inactive)
38 catalysts
Marketed
Doxil
Doxil (doxorubicin hydrochloride)
Kaposi Sarcoma
$BAXBAXTER INTERNATIONAL INC
29 catalysts
Marketed
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM (LEUCOVORIN CALCIUM)
Metastatic Colorectal Cancer
Avyxa Pharma LLC
6 catalysts
Marketed
EVEROLIMUS
EVEROLIMUS (EVEROLIMUS)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Novugen Pharma (Malaysia) Sdn Bhd
6 catalysts
Marketed
apalutamide
Erleada (apalutamide [INN])
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJJOHNSON & JOHNSON
15 catalysts
Marketed
teclistamab
Tecvayli (teclistamab-cqyv)
Refractory Multiple Myeloma
Janssen Biotech Inc
11 catalysts
Marketed
talquetamab
Talvey (talquetamab-tgvs)
Refractory Multiple Myeloma
G-protein coupled receptor family C group 5 member DT cell surface glycoprotein CD3
$JNJJOHNSON & JOHNSON
8 catalysts
Marketed
lurbinectedin
Zepzelca (lurbinectedin)
Ewing Sarcoma
$JAZZJazz Pharmaceuticals plc
6 catalysts
Marketed
luspatercept
Reblozyl (luspatercept-aamt)
Anemia
Celgene Corp
6 catalysts